|
UpDoc UpDate, TEFCA Monitoring, and the Quiet Engine of Healthcare
By Jason Barry, Jack Troy, Virginia Hunt
July 2, 2026
|
|
|
|
|
Together with
|
|
|
|
“FDA clearance is a pretty big hurdle. That’s not just a line in the sand. That’s a big wall in the sand.”
|
|
S32 General Partner Andrew Conrad
|
|
|
If you caught Monday’s DHW, then you probably already know UpDoc landed the first-ever FDA clearance for a patient-facing clinical AI model. What you might not know is everything else that didn’t fit in our 80 word update, so today we’re circling back to see what the milestone might mean for medicine.
Let’s do it.
Jason
|
|
|
|
UpDoc just landed the first FDA clearance for a patient-facing AI model, which acts as a “concierge doctor” to support patients between visits. Good news for the human docs reading this – it isn’t going after your job just yet.
What’s UpDoc? It’s a clinical AI platform that unifies clinical guidelines, longitudinal patient context, and physician governance to safely execute real-world care workflows.
What isn’t UpDoc? An AI doctor.
- The 510(k) clearance had a narrow scope. It allows the AI to call or message patients between visits and adjust their insulin doses within parameters set by human clinicians.
- UpDoc says its AI will ease doctors’ workloads and help patients better manage illnesses like Type 2 diabetes.
The data backs that up. A study in JAMA Network Open saw 32 patients with T2D randomized to receive support from UpDoc (daily voice AI check-ins to record blood glucose and adjust insulin) or standard care (AKA log their own data until they see their doctor in person).
- The AI group hit their target blood glucose in 15 days, compared to the standard care group where less than half got there at all within the 8 week study period.
- That trial provided the clinical foundation for the now-cleared solution, which is set to be piloted at Cleveland Clinic, UCSF Health, and Allegheny Health Network.
UpDoc is taking the road less traveled. It’s not the only AI startup in this wheelhouse, but so far it’s one of the only ones that doesn’t seem to be actively avoiding FDA regulation.
- The most notable example is Doctronic, which has been testing its AI prescription tech through a state-run program in Utah rather than seeking a full-fledged authorization.
- That’s an easier path to market than vaulting over FDA hurdles, but it doesn’t get you the “world first” feather in your cap that now belongs to UpDoc.
So, now what? The FDA has long debated how to regulate AI, and UpDoc could be the first sign that they’re getting comfortable enough with the tech to give the green light to more models.
- With the first clearance out of the way, other AI developers also have an established precedent and a blueprint to follow suit.
Don’t forget about the docs. Besides the regulatory shakeout, it’ll be equally interesting to see how this new breed of AI ends up in the hands of clinicians.
- We saw OpenEvidence fold a new biomarker for heart disease into its platform just last week, and the most direct path to a wide distribution for many soon-to-be-cleared AI tools could be similar licensing partnerships.
- Plenty of companies already have a massive user base and are actively expanding the clinical scope of their platforms – Abridge, OE, Doximity, the list goes on for a while. It feels like licensing models from the UpDocs of the world is a natural next step after all the journal partnerships we’ve been seeing now that FDA clearance is part of the picture.
The Takeaway
The FDA finally cleared its first patient-facing clinical AI model, and UpDoc might have been the first domino, but it definitely won’t be the last.
|
|
Redefining Patient Monitoring for Obesity & Diabetes
Weight management programs live and die by adherence. Discover why partners like Calibrate,
9am Health, and Wondr Health trust Withings to keep members weighing in, with
cellular-connected scales that deliver instant weight insights, full body composition data, and the
lowest possible barrier to action throughout their weight loss journey.
|
|
Execution for Every Workflow
Health systems have no shortage of ideas for improving care and operations. Bunkerhill lets them bring those ideas to life – at scale, across service lines, and around the clock. Discover how the Carebricks platform is empowering clinical and operational teams to deploy AI agents that turn the data they have into the actions they need.
|
|
- Heidi Dictate Debut: Heidi just took the lid off Heidi Dictate, bringing the same medically-tuned voice recognition tech that doctors love in the scribe to wherever their cursor is located. Heidi Dictate is a hotkey away with the Heidi desktop app, working anywhere on the computer from EHRs and booking platforms to emails, messaging apps, and documents. There’s no voice training required and it works for over 90 languages straight out of the box..
- Dealmakers Get Disciplined: A PwC report found U.S. dealmakers were picky about their health services acquisitions during the first five months of 2026. Buyers put a premium on assets that could scale without much labor growth and handle ongoing cost and reimbursements pressures. For AI ventures hoping to get scooped up, demonstrated impact carried much more weight than pilot-stage promise. Despite the more selective landscape, M&A value reached $29B through May, up from just $17B by the midpoint of 2025.
- Withings Acquires Biosensy: Withings offered a glimpse into the future of its RPM platform with the acquisition of Biosency, a French medtech company specializing in remote monitoring for chronic respiratory diseases like COPD. While Biosency’s medically certified algorithms are currently focused on Europe, it’s likely only a matter of time before new capabilities expand to the U.S. market as Withings continues its aggressive shift from a consumer device company into an enterprise platform capable of managing multiple complex chronic conditions under one ecosystem.
- Oura + LillyDirect: Oura’s transformation into a bonafide healthcare company took another step forward with a new LillyDirect partnership, bringing the smartrings to Eli Lilly’s direct-to-consumer telehealth platform. The idea is to help patients that are managing their weight with GLP-1s through an easier way to track changes in their health. The collaboration reportedly doesn’t involve any data sharing, and only introduces LillyDirect customers to the Oura ecosystem through a complementary ring sizing kit.
- Personify Teams Up With Solera: Personify Health and Solera Health are teaming up to embed Solera’s digital health network directly into Personify’s member engagement platform, which serves 25M members. The result is a ready-to-deploy digital health benefit for health plans that doesn’t require any new infrastructure. Solera’s network of 30+ clinically validated programs spans behavioral health, cardiometabolic, MSK, and weight management – operating on a pay-for-performance, claims-based model where payment is tied to outcomes delivered, not services rendered (a strategy that’s producing $1,241 in total cost of care savings per member over six months).
- The Quiet Engine of Healthcare: A great issue of Robert Longyear’s Health Tech Happy Hour mapped out why the Medicare Physician Fee Schedule needs an overhaul, and what CMS has been doing about it. The article offers solid evidence for why measuring the cost of care based on human time and an abstract concept of intensity is “a shaky method” for valuing the services that serve as the foundation of U.S. healthcare finance. On the bright side, Longyear believes that changes CMS proposed this year could bring a much needed shakeup.
- More Monitoring for TEFCA: HHS contracted with an unnamed firm to bolster oversight of TEFCA, reflecting rising concerns over the vulnerability of health data to bad actors. The agency is upping compliance checks on QHINs and their participants to stop fraud and information blocking, with the crackdown arriving in the wake of Epic’s ongoing lawsuit against Health Gorilla for allegedly monetizing almost 300k records pulled from interoperability networks. Since January 2025, the number of records exchanged on TEFCA has soared from ~10M to over 1B.
- Trase Raises $107M: Propelled by a promising partnership with Duke Health, Trase scored an eyewatering $107M in seed funding to further develop its AI OS and grow its go-to-market team. Trase, which exited stealth last fall with a $10.5M pre-seed round, says its agents can triage faxes 7.1x faster than staff at the Duke Division of Cardiology. The startup’s survival will likely hinge on hard outcomes more than most competitors because of its performance-based billing model.
- Half of Americans Can’t Afford Healthcare: A recent Gallup poll revealed that 51% of Americans can’t consistently afford healthcare, a whopping 12 point climb from 2022 and new five-year low. The survey of 5,660 U.S. adults revealed that 10% are classified as “cost desperate,” meaning that both care and medicine are too expensive to access. The numbers unfortunately, but unsurprisingly, reflect ongoing healthcare disparities, as Black and Hispanic populations, women, and those with chronic conditions are more likely to face cost insecurity.
- Hallmark Gifts AI Automation: Hallmark Health Care Solutions launched a new AI platform to decode the “black box” of workforce spending. With $900B spent annually on healthcare labor, Hallmark hopes to consolidate finances in one place and reduce confusion caused by siloed departmental spending. Hallmark already works with 50 health systems to manage over $10B, and has reportedly brought them some impressive improvements like 65% better operating margins and a 80% reduction in compensation errors.
|
|
Evidence, in the Flow of Care
Heidi brings trusted guidelines and peer-reviewed research directly into clinical workflows so decisions don’t stall care. Clinicians get clear, evidence-based answers without leaving the conversation. No ads, no limits, and no outside interests getting in the way of care. Find out how with Heidi Evidence.
|
|
Clinician-First Copilot for Value-Based Success
Navina’s AI copilot brings clinical intelligence directly to care teams, turning fragmented data into actionable insights that transform value-based workflows from the back office to the point-of-care. Designed for and loved by physicians, Navina’s Best in KLAS AI reduces missed diagnoses while improving quality metrics and risk adjustment accuracy. Discover how practices are leveraging Navina to enhance VBC performance and improve the clinician experience.
|
|
State of Payer Enrollment and Credentialing
Over half of provider orgs are losing revenue due to credentialing delays – with many missing out on over $1M annually. Medallion’s new report unpacks the forces quietly undermining operational and financial performance, and how leaders across the industry are addressing them. Check out the full report to get insights tailored to your role and org type.
|
|
- Abridge Named #1 Best in KLAS – Again: KLAS just named Abridge #1 Best in KLAS for Ambient AI for the second year in a row. The recognition was based on direct customer feedback from the nation’s largest and most complex health systems, which gave Abridge the highest overall satisfaction score and A+ ratings across Culture, Loyalty, Relationship, and Value. Discover why Abridge is the market-leading AI platform for clinical conversations.
- A New Path for ACCESS Model Participants: Building your CMS ACCESS program? Withings was accepted into the inaugural cohort as both a participant and a device partner via the ACCESS Tools Directory. Bring the same FDA-cleared, cellular-enabled devices into your program, including BPM Pro 2, capturing clinical measurements and patient-reported outcomes at the point of reading, purpose-built for value-based cardio-kidney-metabolic care.
- State of Payor Enrollment and Credentialing: Over half of provider orgs are losing revenue due to credentialing delays – with many missing out on over $1M annually. Medallion’s new report unpacks the forces quietly undermining operational and financial performance, and how leaders across the industry are addressing them. Head over to the full report to get insights tailored to your role and org type.
|
|
|
|
|
